[go: up one dir, main page]

FR3598M - Medicinal product for the treatment of people suffering from poor absorption of fat. - Google Patents

Medicinal product for the treatment of people suffering from poor absorption of fat.

Info

Publication number
FR3598M
FR3598M FR964600A FR964600A FR3598M FR 3598 M FR3598 M FR 3598M FR 964600 A FR964600 A FR 964600A FR 964600 A FR964600 A FR 964600A FR 3598 M FR3598 M FR 3598M
Authority
FR
France
Prior art keywords
fat
treatment
medicinal product
people suffering
poor absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR964600A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drew Chemical Corp
Original Assignee
Drew Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drew Chemical Corp filed Critical Drew Chemical Corp
Application granted granted Critical
Publication of FR3598M publication Critical patent/FR3598M/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Seasonings (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
FR964600A 1963-03-15 1964-02-21 Medicinal product for the treatment of people suffering from poor absorption of fat. Expired FR3598M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26532563A 1963-03-15 1963-03-15

Publications (1)

Publication Number Publication Date
FR3598M true FR3598M (en) 1965-10-11

Family

ID=38570917

Family Applications (1)

Application Number Title Priority Date Filing Date
FR964600A Expired FR3598M (en) 1963-03-15 1964-02-21 Medicinal product for the treatment of people suffering from poor absorption of fat.

Country Status (2)

Country Link
ES (2) ES297549A1 (en)
FR (1) FR3598M (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014910A1 (en) * 1979-02-16 1980-09-03 Carl-Jacob Gatzen Wholly acetylated monoglycerides for use for lowering of raised levels of cholesterol and/or neutral fats in human blood and process for production of pharmaceutical compositions for this purpose and dietetic foodstuffs containing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014910A1 (en) * 1979-02-16 1980-09-03 Carl-Jacob Gatzen Wholly acetylated monoglycerides for use for lowering of raised levels of cholesterol and/or neutral fats in human blood and process for production of pharmaceutical compositions for this purpose and dietetic foodstuffs containing them

Also Published As

Publication number Publication date
ES301602A1 (en) 1965-01-16
ES297549A1 (en) 1964-09-01

Similar Documents

Publication Publication Date Title
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
CH417844A (en) Apparatus for the treatment of a liquid
FR3010M (en) New drugs derived from benzene for the treatment of heart disease.
FR1369M (en) New products for the treatment of visual acuity.
FR1215M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenia.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3598M (en) Medicinal product for the treatment of people suffering from poor absorption of fat.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3526M (en) Therapeutic composition for the treatment of acne.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
BE772424A (en) DERMOPHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SEBORREHEIC AFFECTIONS
FR3269M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2913M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2656M (en) New drug, in particular for the treatment of chronic or postprandial hyperlipemia.
FR2940M (en) Medicinal product for the treatment of arterial disease based on glyoxylic acid.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR2684M (en) Pharmaceutical composition for the local treatment of rheumatic pain.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR3031M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3057M (en) Medicine for the treatment of skin disease.
FR2817M (en) Combinations of drugs for the treatment of mental disorders.